Article Details
Retrieved on: 2024-03-07 17:02:04
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details Merck KGaA's financial downturn in 2023, with CEO Belén Garijo attributing the declines to market challenges but expecting future growth. It relates to 'biopharma' through Merck's sector performance, involves companies like 'Merck & Co.' and locations like 'Kenilworth, New Jersey', and references sources like 'GlobalData' and platforms such as 'LinkedIn'.
Article found on: www.pharmaceutical-technology.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here